| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Gastroenterology, Hepatology, and Endocrinology, Medical School Hannover, Germany;
* Department of Visceral Surgery, Medical School Hannover, Germany;
Department of Pathology, Medical School Hannover, Germany; and
Department of Immunology and Oncology, Centro National de Biotecnologia/CSIC, Madrid, Spain
2Correspondence: Department of Gastroenterology, Hepatology, and Endocrinology, Medical School Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. E-mail: Rudolph.Lenhard{at}Mh-Hannover.de
Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lymphocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte-specific telomere shortening correlated with senescence-associated ß-galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
Key Words: telomerase • regeneration • chronic disease • fibrosis • stellate cell activation
This article has been cited by other articles:
|
|
 |
|
  M. Mangino, S. Brouilette, P. Braund, N. Tirmizi, M. Vasa-Nicotera, J. R. Thompson, and N. J. Samani A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans Hum. Mol. Genet., August 15, 2008; 17(16): 2518 - 2523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease PNAS, August 12, 2008; 105(32): 11299 - 11304.
|
|
|
|
 |
|
 I. Siegl-Cachedenier, I. Flores, P. Klatt, and M. A. Blasco Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres J. Cell Biol., October 22, 2007; 179(2): 277 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shen, M. B. Terry, I. Gurvich, Y. Liao, R. T. Senie, and R. M. Santella Short Telomere Length and Breast Cancer Risk: A Study in Sister Sets Cancer Res., June 1, 2007; 67(11): 5538 - 5544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsuji, K. Aoshiba, and A. Nagai Alveolar Cell Senescence in Patients with Pulmonary Emphysema Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 886 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.J. Mooi and D.S. Peeper Oncogene-induced cell senescence--halting on the road to cancer. N. Engl. J. Med., September 7, 2006; 355(10): 1037 - 1046. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Farazi, J. Glickman, J. Horner, and R. A. DePinho Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression. Cancer Res., May 1, 2006; 66(9): 4766 - 4773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Shay and W. E. Wright Senescence and immortalization: role of telomeres and telomerase Carcinogenesis, May 1, 2005; 26(5): 867 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsuji, K. Aoshiba, and A. Nagai Cigarette Smoke Induces Senescence in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Sato, C Maesawa, K Fujisawa, K Wada, K Oikawa, Y Takikawa, K Suzuki, H Oikawa, K Ishikawa, and T Masuda Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis Gut, July 1, 2004; 53(7): 1001 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Satyanarayana, R. A. Greenberg, S. Schaetzlein, J. Buer, K. Masutomi, W. C. Hahn, S. Zimmermann, U. Martens, M. P. Manns, and K. L. Rudolph Mitogen Stimulation Cooperates with Telomere Shortening To Activate DNA Damage Responses and Senescence Signaling Mol. Cell. Biol., June 15, 2004; 24(12): 5459 - 5474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schaetzlein, A. Lucas-Hahn, E. Lemme, W. A. Kues, M. Dorsch, M. P. Manns, H. Niemann, and K. L. Rudolph Telomere length is reset during early mammalian embryogenesis PNAS, May 25, 2004; 101(21): 8034 - 8038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aoshiba, T. Tsuji, and A. Nagai Bleomycin induces cellular senescence in alveolar epithelial cells Eur. Respir. J., September 1, 2003; 22(3): 436 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Farazi, J. Glickman, S. Jiang, A. Yu, K. L. Rudolph, and R. A. DePinho Differential Impact of Telomere Dysfunction on Initiation and Progression of Hepatocellular Carcinoma Cancer Res., August 15, 2003; 63(16): 5021 - 5027. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
